Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
Nov 4, 2025, 12:23 PM EST

Telesis Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
17.0327.5127.4411.046.585.77
Revenue Growth
-32.54%0.27%148.44%67.93%14.05%-
Gross Profit
7.9816.9515.64.33.632.55
Operating Income
-31.25-35.15-46.49-35.07-16.36-8.37
Net Income
-47.93-49.02-48.47-38.96-18.01-9.96
Earnings Per Share
-28.02-29.56-29.61-38.48-64.82-35.86
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
4.5119.1643.5882.8113.4629.14
Total Debt
16.2934.3821.4317.328.334.77
Net Cash (Debt)
-11.78-15.2222.1565.485.1424.38
Net Cash Growth
---66.17%1174.75%-78.93%-
Net Cash Per Share
-6.89-9.1813.5364.6818.4987.75

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-22.87-34.67-38.72-36.7-15.38-7.67
Capital Expenditures
-0.99-1.98-4.47-1.85-0.2-0.09
Free Cash Flow
-23.86-36.65-43.18-38.55-15.59-7.76
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
46.87%61.62%56.84%38.93%55.13%44.29%
Operating Margin
-183.44%-127.78%-169.44%-317.61%-248.80%-145.18%
Pretax Margin
-264.56%-173.40%-176.59%-352.66%-273.80%-172.78%
Profit Margin
-281.36%-178.21%-176.68%-352.78%-273.88%-172.78%
FCF Margin
-140.08%-133.22%-157.40%-349.11%-237.00%-134.63%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
0.000.441.2928.66--